Efficacy, Safety, Tolerability of Neramexane in Patients With Subjective Tinnitus

Clinical trial NCT00955799 · COMPLETED

Trial details

NCT number: NCT00955799
Sponsor: Merz Pharmaceuticals GmbH
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Subjective Tinnitus

Start date: 2009-09-01
Primary completion: 2011-05-01
Enrollment: 455

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.